SCHEMBL31359276

SCHEMBL31359276

O=C(Nc1ccccc1)c1cc(Cl)cc(Cl)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.59
▸ USP2 O75604 1/20 0.57
▸ HTT P42858 1/20 0.57
▸ CNR2 P34972 1/20 0.54
▸ RAB9A P51151 4/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ NFKB2 Q00653 1/20 0.51
▸ RELA Q04206 1/20 0.51
▸ CNR1 P21554 3/20 0.50
▸ EGFR P00533 1/20 0.50
▸ TMPRSS4 Q9NRS4 1/20 0.50
▸ GRM4 Q14833 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23413100 1.00 POLB (0.59) POLBUSP2HTTCNR2RAB9A
SCHEMBL23413329 0.83 GAA (0.60) RAB9AKMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL30097611 0.83 GAA (0.60) RAB9AKMT2AMEN1NPSR1SMN1; SMN2
SCHEMBL15575804 0.79 POLB (0.79) POLBUSP2HTTCNR2RAB9A
SCHEMBL19382699 0.79 HTT (0.60) POLBUSP2HTTRAB9AKMT2A
SCHEMBL23444620 0.79 EGFR (0.47) POLBUSP2HTTCNR2RAB9A
SCHEMBL23413118 0.78 RAB9A (0.57) POLBRAB9AKMT2AMEN1MAPT
SCHEMBL30097503 0.78 RAB9A (0.57) POLBRAB9AKMT2AMEN1MAPT
SCHEMBL16396288 0.77 SUCNR1 (0.55) —
SCHEMBL6072225 0.77 GRM4 (0.65) POLBCNR2RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115348959-B Heteroaryl compounds and their therapeutic use in conditions associated with altered beta-glucocerebrosidase activity GT增益治疗股份有限公司 2025-01-07 — — CN disclosed
Send feedback